1. p53/MicroRNA-34 axis in cancer and beyond
   Wei Pan et al, 2023, Heliyon CrossRef
2. Dysregulation of P53 in breast cancer: Causative factors and treatment strategies
   Navid Shomali et al, 2023, Pathology - Research and Practice CrossRef
3. PRIMA-1MET Does Not Restore Vitamin D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast Cancer Cells
   Shadi N. Kotob et al, 2023, ACS Omega CrossRef
4. Approaches to anticancer therapy based on modulation of DNA methylation
   V. P. Maksimova et al, 2024, Siberian journal of oncology CrossRef
5. Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival
   Tao Xie et al, 2022, Cancers CrossRef
6. ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerability
   Kiran Kumar Reddi et al, 2024, Cell Death & Disease CrossRef